These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20586119)

  • 1. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful gene therapy of mice with congenital erythropoietic porphyria].
    de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
    Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
    Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
    Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.
    Robert-Richard E; Moreau-Gaudry F; Lalanne M; Lamrissi-Garcia I; Cario-André M; Guyonnet-Dupérat V; Taine L; Ged C; de Verneuil H
    Am J Hum Genet; 2008 Jan; 82(1):113-24. PubMed ID: 18179890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital erythropoietic porphyria.
    To-Figueras J; Erwin AL; Aguilera P; Millet O; Desnick RJ
    Liver Int; 2024 Aug; 44(8):1842-1855. PubMed ID: 38717058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular study of congenital erythropoietic porphyria in cattle.
    Agerholm JS; Thulstrup PW; Bjerrum MJ; Bendixen C; Jørgensen CB; Fredholm M
    Anim Genet; 2012 Apr; 43(2):210-5. PubMed ID: 22404357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
    Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
    Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
    Bedel A; Taillepierre M; Guyonnet-Duperat V; Lippert E; Dubus P; Dabernat S; Mautuit T; Cardinaud B; Pain C; Rousseau B; Lalanne M; Ged C; Duchartre Y; Richard E; de Verneuil H; Moreau-Gaudry F
    Am J Hum Genet; 2012 Jul; 91(1):109-21. PubMed ID: 22795135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer.
    Moreau-Gaudry F; Ged C; Barbot C; Mazurier F; Boiron JM; Bensidhoum M; Reiffers J; de Verneuil H
    Hum Gene Ther; 1995 Jan; 6(1):13-20. PubMed ID: 7703283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
    Frank J; Wang X; Lam HM; Aita VM; Jugert FK; Goerz G; Merk HF; Poh-Fitzpatrick MB; Christiano AM
    Ann Hum Genet; 1998 May; 62(Pt 3):225-30. PubMed ID: 9803266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital erythropoietic porphyria].
    Tanigawa K; Takamura N; Yamashita S
    Nihon Rinsho; 1995 Jun; 53(6):1422-6. PubMed ID: 7616657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
    Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H
    J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
    Ged C; Moreau-Gaudry F; Richard E; Robert-Richard E; de Verneuil H
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):53-60. PubMed ID: 19268002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
    Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria.
    Fortian A; Castaño D; Gonzalez E; Laín A; Falcon-Perez JM; Millet O
    Adv Protein Chem Struct Biol; 2011; 83():43-74. PubMed ID: 21570665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.